Advertisement Safeway and the Prostate Cancer Foundation to fund cancer research - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Safeway and the Prostate Cancer Foundation to fund cancer research

Safeway and the Prostate Cancer Foundation are to collectively donate $6 million to fund the STAR program, a research initiative focused on exploring the role of targeted heat in cancer therapy to treat prostate cancer, as well as other research strategies.

The STAR (Special Team Amplification of Research) program is being launched for the first Phase of research and development with a $3 million grant from the Safeway Foundation, which raised the funds from its customers with donations made at checkout. The Prostate Cancer Foundation (PCF) developed the collaborative research partnership and matched the initial funds dollar-for-dollar, for a total $6 million commitment.

The program brings together an interdisciplinary team of investigators from multiple cancer research centers to focus on a new approach to prostate cancer treatment. The team consists of investigators from the Johns Hopkins University School of Medicine (program lead and coordinator), the University of Michigan Cancer Center and the University of British Columbia.

Jonathan Simons, CEO and president of the Prostate Cancer Foundation, said: “The STAR program is evidence of what can happen when you link the fundraising power of a major company like Safeway with the research vision
of the Prostate Cancer Foundation. This program would not have happened without Safeway and its long-standing commitment to helping find a cure for prostate cancer. We are literally turning up the heat on metastatic prostate cancer research.”